CORBUS PHARMACEUTICALS HOLDI (CRBP)

US21833P3010 - Common Stock

39.24  +3.67 (+10.32%)

After market: 39.9944 +0.75 (+1.92%)

Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to CRBP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 49.47. This target is 26.07% above the current price.
CRBP was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CRBP.
In the previous month the buy percentage consensus was at a similar level.
CRBP was analyzed by 7 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 39.2446.4649.4749.4753.55 - 18.40% 26.07% 26.07% 36.47%
Up and Down Grades
Date Firm Action Rating
2024-03-13 Oppenheimer Reiterate Outperform -> Outperform
2024-03-06 Jefferies Upgrade Hold -> Buy
2024-01-29 Oppenheimer Maintains Outperform -> Outperform
2023-08-09 Oppenheimer Reiterate Outperform -> Outperform
2023-05-10 Oppenheimer Upgrade Perform -> Outperform
2023-03-08 HC Wainwright & Co. Reiterate Buy
2023-02-14 HC Wainwright & Co. Reiterate Buy